BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 8879208)

  • 1. Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells.
    Tajima S; Tsuji K; Ebihara Y; Sui X; Tanaka R; Muraoka K; Yoshida M; Yamada K; Yasukawa K; Taga T; Kishimoto T; Nakahata T
    J Exp Med; 1996 Oct; 184(4):1357-64. PubMed ID: 8879208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells.
    Sui X; Tsuji K; Tanaka R; Tajima S; Muraoka K; Ebihara Y; Ikebuchi K; Yasukawa K; Taga T; Kishimoto T
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2859-63. PubMed ID: 7535932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble interleukin-6 (IL-6) receptor with IL-6 stimulates megakaryopoiesis from human CD34(+) cells through glycoprotein (gp)130 signaling.
    Sui X; Tsuji K; Ebihara Y; Tanaka R; Muraoka K; Yoshida M; Yamada K; Yasukawa K; Taga T; Kishimoto T; Nakahata T
    Blood; 1999 Apr; 93(8):2525-32. PubMed ID: 10194431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic action of Flt3 and gp130 signalings in human hematopoiesis.
    Ebihara Y; Tsuji K; Lyman SD; Sui X; Yoshida M; Muraoka K; Yamada K; Tanaka R; Nakahata T
    Blood; 1997 Dec; 90(11):4363-8. PubMed ID: 9373247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
    Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y
    Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin-independent erythrocyte production: signals through gp130 and c-kit dramatically promote erythropoiesis from human CD34+ cells.
    Sui X; Tsuji K; Tajima S; Tanaka R; Muraoka K; Ebihara Y; Ikebuchi K; Yasukawa K; Taga T; Kishimoto T; Nakahata T
    J Exp Med; 1996 Mar; 183(3):837-45. PubMed ID: 8642288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous activation of signals through gp130, c-kit, and interleukin-3 receptor promotes a trilineage blood cell production in the absence of terminally acting lineage-specific factors.
    Kimura T; Sakabe H; Tanimukai S; Abe T; Urata Y; Yasukawa K; Okano A; Taga T; Sugiyama H; Kishimoto T; Sonoda Y
    Blood; 1997 Dec; 90(12):4767-78. PubMed ID: 9389693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 6 receptor expression by human cord blood- or peripheral blood-derived primitive haematopoietic progenitors implies acquisition of different functional properties.
    Minamiguchi H; Yahata N; Kimura T; Fujiki H; Harada S; Wang J; Okuda K; Kaneko H; Hodohara K; Banba T; Yasukawa K; Ohyashiki JH; Ohyashiki K; Abe T; Sonoda Y
    Br J Haematol; 2000 Aug; 110(2):327-38. PubMed ID: 10971389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of glycoprotein 130 and c-Kit signaling in proliferation and differentiation of human hematopoietic progenitor cells.
    Nakahata T; Sui X; Tanaka R; Tajima S; Muraoka K; Ebihara Y; Tsuji K
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S64-8. PubMed ID: 8765420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric cytokine receptor can transduce expansion signals in interleukin 6 receptor alpha (IL-6Ralpha)-, IL-11Ralpha-, and gp130-low to -negative primitive hematopoietic progenitors.
    Takagi M; Nakamura T; Sawada T; Kaneko A; Nozaki-Ukai M; Nakahata T; Yokota T; Heike T
    Mol Biol Cell; 1999 Nov; 10(11):3633-42. PubMed ID: 10564261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation of individual hematopoietic progenitors purified from umbilical cord blood.
    Mayani H; Lansdorp PM
    Exp Hematol; 1995 Dec; 23(14):1453-62. PubMed ID: 8542931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 directly modulates stem cell factor-dependent development of human mast cells derived from CD34(+) cord blood cells.
    Kinoshita T; Sawai N; Hidaka E; Yamashita T; Koike K
    Blood; 1999 Jul; 94(2):496-508. PubMed ID: 10397717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin augments ex vivo expansion of human cord blood-derived hematopoietic progenitors in combination with stem cell factor and flt3 ligand.
    Ohmizono Y; Sakabe H; Kimura T; Tanimukai S; Matsumura T; Miyazaki H; Lyman SD; Sonoda Y
    Leukemia; 1997 Apr; 11(4):524-30. PubMed ID: 9096693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replating potential of colony-forming units of granulocytes/macrophages (CFU-GM) expanded ex vivo by stem cell factor, interleukin (IL)-3, IL-6, granulocyte colony-stimulating factor, erythropoietin with or without thrombopoietin.
    Katayama Y; Takenaka K; Mahmut N; Teshima T; Shinagawa K; Omoto E; Harada M
    Int J Hematol; 1998 Aug; 68(2):157-68. PubMed ID: 9803674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombopoietin alone stimulates the early proliferation and survival of human erythroid, myeloid and multipotential progenitors in serum-free culture.
    Yoshida M; Tsuji K; Ebihara Y; Muraoka K; Tanaka R; Miyazaki H; Nakahata T
    Br J Haematol; 1997 Aug; 98(2):254-64. PubMed ID: 9266917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
    Ruggieri L; Heimfeld S; Broxmeyer HE
    Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.